Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,390.00    -65.00 (-1.19%)
Bid:
5,410.00
Ask:
5,420.00
Spread: 10.00 (0.185%)
Market Cap: £3.92b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Interim Management Statement

15 Oct 2009 11:06

RNS Number : 8319A
Renishaw PLC
15 October 2009
 



Renishaw plc

Interim Management Statement

This statement has been prepared for the Group and relates to the three months ended 30th September 2009. It contains unaudited information that covers the first quarter and the period since the quarter end to the date of this interim management statement.

Trading activity

The recent improvements in order intake and revenue reported on 29th September 2009 have continued, but are still substantially below that of twelve months ago. In the first quarter, good growth has been experienced in the Far East, compared with the last two quarters of the previous year. In product terms, the strongest increase in demand has been for our Encoder products and there has been an encouraging recovery for most other product lines, with order intake still running ahead of sales. Spectroscopy has seen an increase in sales compared with the same quarter last year.

In the three-month period, the operating profit amounted to £1.3m and the profit before tax amounted to £2.0m compared to £9.8m last year on revenue of £32.5m, down from £53.0m last year. Revenue at previous year exchange rates would have been lower by £2.3m and the profit before tax lower by £1.2m.

The Board has restored half the voluntary 20% reduction in salaries from 1st October 2009 to 31st December 2009 at which time salaries will be fully restored. Provision will be made for further payment, which may take employees back up to full salary for part of the period, depending upon group performance up to 31st December 2009 and, if appropriate, will be paid within the December 2009 payroll. 

The Group continues to invest strongly in research and development programmes in both the Metrology and Healthcare sectors and a number of new products are being introduced in this financial year, some of which were exhibited at the EMO exhibition held last week in MilanItaly.

Current indications are that there will be an improvement in Group profits for the year, although the overall outcome is expected to be well below the level of two years ago. 

Financial position, significant events and transactions

The Group has a strong balance sheet and there is a continuing focus on working capital management. At 30th September 2009, net cash balances amounted to £21.9m.

There have been no other significant events or transactions that could have had a material impact on the financial position of the Group over the period since the beginning of the financial year.

Sir David McMurtry CBE, RDIFREng, CEng, FIMechE

Chairman and Chief Executive

15th October 2009

Renishaw plc

Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number 1106260

Telephone number 01453 524524

Website www.renishaw.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMABMTMMMBBIL
Date   Source Headline
16th May 20239:45 amRNSAGM Voting Results Update Statement
9th May 20233:39 pmRNSNotice of Investor Day
28th Apr 20237:00 amRNSTrading Statement
2nd Feb 20237:00 amRNSHalf-year Report
24th Jan 20233:11 pmRNSNotice of Half-year Results
30th Nov 20224:38 pmRNSResult of AGM
31st Oct 20221:00 pmRNSNotice of AGM
28th Oct 20229:15 amRNSDirector/PDMR Shareholding
27th Oct 20227:00 amRNSTrading Statement
30th Sep 20227:00 amRNSAnnual Financial Report
29th Sep 202210:12 amRNSDirector/PDMR Shareholding
15th Sep 20227:00 amRNSFinal Results
6th Sep 20221:00 pmRNSNotice of Results
1st Jul 202212:31 pmRNSDirector Declaration
16th May 20225:56 pmRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSAGM Voting Results Update Statement
10th May 20227:00 amRNSTrading Statement
12th Apr 202211:44 amRNSNotice of Investor Day
12th Apr 202210:58 amRNSDirector/PDMR Shareholding
31st Mar 20221:00 pmRNSDirectorate Change
18th Mar 20222:08 pmRNSHolding(s) in Company
14th Mar 20225:58 pmRNSDirector/PDMR Shareholding
1st Mar 20224:23 pmRNSDirectorate Change
3rd Feb 20227:00 amRNSHalf-year Report
17th Jan 20221:00 pmRNSNotice of Half-year Results
20th Dec 20214:05 pmRNSDirectorate Change
24th Nov 20213:57 pmRNSResult of AGM
29th Oct 20218:00 amRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSAnnual Financial Report
21st Oct 202111:50 amRNSFinal Results Replacement
21st Oct 20217:00 amRNSFinal Results
21st Oct 20217:00 amRNSTrading Statement
27th Sep 202110:52 amRNSFinal Results Revised Date and Trading Update
17th Sep 202110:35 amRNSNotice of Results
31st Aug 202112:31 pmRNSHolding(s) in Company
3rd Aug 20213:05 pmRNSDirector/PDMR Shareholding
8th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
8th Jul 20217:00 amRNSForm 8.3
7th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
7th Jul 20213:13 pmRNSForm 8.3 - Renishaw plc
7th Jul 20212:26 pmEQSForm 8.3 - The Vanguard Group, Inc.: Renishaw plc
7th Jul 202111:48 amRNSForm 8.5 (EPT/NON-RI) - Renishaw plc
7th Jul 202111:14 amRNSForm 8.5 (EPT/RI) - Renishaw Plc
7th Jul 20217:00 amRNSUpdate on Formal Sale Process & Current Trading
6th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
6th Jul 20213:09 pmRNSForm 8.3 - Renishaw plc
6th Jul 20212:38 pmRNSForm 8.3 - Renishaw Plc
6th Jul 20212:13 pmRNSForm 8.3 - Renishaw Plc
6th Jul 20212:05 pmEQSForm 8.3 - The Vanguard Group, Inc.: Renishaw plc
6th Jul 202111:36 amRNSForm 8.5 (EPT/RI) - Renishaw Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.